PMID- 36096355 OWN - NLM STAT- MEDLINE DCOM- 20221018 LR - 20221026 IS - 1873-4596 (Electronic) IS - 0891-5849 (Linking) VI - 192 DP - 2022 Nov 1 TI - Silencing SIRT5 induces the senescence of UCB-MSCs exposed to TNF-alpha by reduction of fatty acid beta-oxidation and anti-oxidation. PG - 1-12 LID - S0891-5849(22)00583-4 [pii] LID - 10.1016/j.freeradbiomed.2022.09.002 [doi] AB - Tumor necrosis factor-alpha (TNF-alpha) is an inflammatory cytokine involved in cell survival, apoptosis, and homeostasis. However, the regulatory effect of TNF-alpha on mesenchymal stem cell (MSC) redox regulation remains unknown. The process of delaying the senescence of MSCs and maintaining antioxidation mechanism is important in transplantation therapy to treat inflammatory diseases that result from restricted immunomodulatory effects of senescent MSCs. Thus, we examined the role of TNF-alpha-mediated signaling and its regulatory mechanisms on the senescence of umbilical cord blood-derived MSCs (UCB-MSCs) and identified its therapeutic efficacy in a collagen-induced arthritis (CIA) mouse model. We found that TNF-alpha increased fatty acid synthesis and lipid droplet (LD) formation through NF-kappaB/SREBP1-mediated FASN, SCD1, and DGAT2 expression, which protects UCB-MSCs from oxidative stress against accumulated toxic lipids. Additionally, DGAT2-mediated LD formation was regulated by TNF-alpha-activated TNF receptor (TNFR)1 signaling. We also found that storage of unsaturated FAs in LDs is regulated by SIRT5-dependent beta-oxidation of FAs, which reduces mitochondrial ROS (mtROS) accumulation. Particularly, mtROS homeostasis was maintained by superoxide dismutase 2 (SOD2) upregulation through TNFR2-mediated SIRT5/Nrf2 signaling. In a CIA mouse model, UCB-MSCs transfected with SIRT5 siRNA exhibited reduced therapeutic effects compared with UCB-MSCs transfected with NT siRNA. Overall, the results indicated that SIRT5 plays a central role in protecting TNF-alpha-induced UCB-MSC senescence through FA beta-oxidation and SOD2-mediated antioxidation. CI - Copyright (c) 2022 Elsevier Inc. All rights reserved. FAU - Jung, Young Hyun AU - Jung YH AD - Department of Veterinary Physiology, College of Veterinary Medicine, Research Institute for Veterinary Science, and BK21 Four Future Veterinary Medicine Leading Education and Research Center, Seoul National University, Seoul, 08826, South Korea. FAU - Chae, Chang Woo AU - Chae CW AD - Department of Veterinary Physiology, College of Veterinary Medicine, Research Institute for Veterinary Science, and BK21 Four Future Veterinary Medicine Leading Education and Research Center, Seoul National University, Seoul, 08826, South Korea. FAU - Chang, Han Seung AU - Chang HS AD - Department of Veterinary Physiology, College of Veterinary Medicine, Research Institute for Veterinary Science, and BK21 Four Future Veterinary Medicine Leading Education and Research Center, Seoul National University, Seoul, 08826, South Korea. FAU - Choi, Gee Euhn AU - Choi GE AD - Laboratory of Veterinary Biochemistry, College of Veterinary Medicine, Jeju National University, Jeju, 63243, South Korea. FAU - Lee, Hyun Jik AU - Lee HJ AD - Laboratory of Veterinary Physiology, College of Veterinary Medicine, Chungbuk National University, Cheongju, Chungbuk, 28644, South Korea; Institute for Stem Cell & Regenerative Medicine (ISCRM), Chungbuk National University, Cheongju, Chungbuk, 28644, South Korea. FAU - Han, Ho Jae AU - Han HJ AD - Department of Veterinary Physiology, College of Veterinary Medicine, Research Institute for Veterinary Science, and BK21 Four Future Veterinary Medicine Leading Education and Research Center, Seoul National University, Seoul, 08826, South Korea. Electronic address: hjhan@snu.ac.kr. LA - eng PT - Journal Article PT - Research Support, Non-U.S. Gov't DEP - 20220909 PL - United States TA - Free Radic Biol Med JT - Free radical biology & medicine JID - 8709159 RN - 0 (Cytokines) RN - 0 (Fatty Acids) RN - 0 (Lipids) RN - 0 (NF-E2-Related Factor 2) RN - 0 (NF-kappa B) RN - 0 (RNA, Small Interfering) RN - 0 (Reactive Oxygen Species) RN - 0 (Receptors, Tumor Necrosis Factor, Type II) RN - 0 (SIRT5 protein, mouse) RN - 0 (Tumor Necrosis Factor-alpha) RN - EC 3.5.1.- (Sirtuins) SB - IM MH - Animals MH - Cytokines/metabolism MH - Disease Models, Animal MH - Fatty Acids MH - Gene Silencing MH - Lipids MH - Mice MH - *NF-E2-Related Factor 2/genetics MH - NF-kappa B/metabolism MH - Oxidation-Reduction MH - RNA, Small Interfering/metabolism MH - Reactive Oxygen Species/metabolism MH - Receptors, Tumor Necrosis Factor, Type II/metabolism MH - *Sirtuins/genetics/metabolism MH - Tumor Necrosis Factor-alpha/genetics/metabolism OTO - NOTNLM OT - Fatty acid oxidation OT - Lipid droplet OT - Mitochondrial reactive oxygen species OT - SIRT5 OT - Superoxide dismutase 2 OT - TNF-alpha COIS- Declaration of competing interest The authors declare no competing interests. EDAT- 2022/09/13 06:00 MHDA- 2022/10/19 06:00 CRDT- 2022/09/12 19:26 PHST- 2022/07/07 00:00 [received] PHST- 2022/08/30 00:00 [revised] PHST- 2022/09/05 00:00 [accepted] PHST- 2022/09/13 06:00 [pubmed] PHST- 2022/10/19 06:00 [medline] PHST- 2022/09/12 19:26 [entrez] AID - S0891-5849(22)00583-4 [pii] AID - 10.1016/j.freeradbiomed.2022.09.002 [doi] PST - ppublish SO - Free Radic Biol Med. 2022 Nov 1;192:1-12. doi: 10.1016/j.freeradbiomed.2022.09.002. Epub 2022 Sep 9.